{"slug":"what-are-peptides-postherpetic","verification":{"valid":true,"entries":2,"head":"5f710d1c99554b10f82081ee06f5c8e822977a4bb28694a375fc5e82a6966cf1"},"energy":{"passes":2,"tokens_in":0,"tokens_out":0,"tokens_total":0,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"5f710d1c99554b10f82081ee06f5c8e822977a4bb28694a375fc5e82a6966cf1"},"provenance":[{"ts":"2026-06-29T21:47:45.667Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: What Are Peptides for Postherpetic\nSlug: what-are-peptides-postherpetic\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\",\"section_headings\":[\"What's breaking down\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from peptide_chains / drug_chains.\",\"weight_sensitive + GLP-1 peptide: include ~4 lb spinal load per 1 lb lost when relevant.\",\"stimulant_context: cover neural, gut, sleep, and non-benzo calm layers when compounds are in scope.\",\"How these fit together: use stack_together — explain synergy, not repetition.\"]}","response":"{\n  \"slug\": \"what-are-peptides-postherpetic\",\n  \"title\": \"What Are Peptides for Postherpetic Neuralgia: Evidence Review\",\n  \"body\": \"## What's breaking down\\n\\nPostherpetic neuralgia develops after shingles, which is reactivation of the varicella-zoster virus. The virus damages sensory neurons in the dorsal root ganglia. This damage triggers ongoing inflammation and changes in how nerves fire signals.\\n\\nDegeneration layers include:\\n\\n1. Direct neuronal injury and loss of myelination around affected nerves.\\n2. Central sensitization where the spinal cord and brain amplify pain signals even after the rash heals.\\n3. Persistent low-grade inflammation that keeps pain pathways active.\\n4. Reduced blood flow and impaired repair in the affected nerve tissue.\\n\\nIf the initial shingles infection overwhelms the body's repair capacity, these layers persist and produce chronic burning, stabbing, or electric pain months or years later. Standard treatments often focus on symptom suppression with anticonvulsants or antidepressants rather than addressing the underlying nerve degeneration.\\n\\nNo condition profile matched a specific peptide stack in available data, so this review examines whether any peptides have been studied for repair pathways in this setting.\\n\\n## How these fit together\\n\\nNo peptide chains appear in the enrichment data for this condition. Single-compound focus applies. Any regenerative compound would target one or more of the layers above without overlap from siblings.\\n\\n## What the evidence actually shows\\n\\nNo human clinical trials exist for any specific peptide in postherpetic neuralgia. Searches of trial registries and systematic reviews of investigational drugs for PHN list compounds such as mirogabalin, EMA401, and lidocaine formulations, but no therapeutic peptides.\\n\\nPreclinical work on nerve injury models (primarily rats) has examined certain peptides for axonal regeneration and reduced inflammation, yet none of these studies used postherpetic neu","tokens_in":0,"tokens_out":0,"cost":0,"prev":"genesis","hash":"4d71ae2984da717c0353cd050e5f1e53e36d2af45dc17e8388c99bdcfe8db631"},{"ts":"2026-07-17T02:43:34.433Z","model":"owner","action":"voxel_divide","prompt":"","input":"what-are-peptides-postherpetic","response":"24 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"4d71ae2984da717c0353cd050e5f1e53e36d2af45dc17e8388c99bdcfe8db631","hash":"5f710d1c99554b10f82081ee06f5c8e822977a4bb28694a375fc5e82a6966cf1"}]}